Shanghai, China
Lilly Asian Ventures invests in venture capital for Eli Lilly and Company, a pharmaceutical corporation focused on innovation with a global reach, specifically in the Asian region.
116
Total Investments
72
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Pharmaceutical
Funding Stage
Seed
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Lilly Asia Ventures
Recent Investments (116)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Debt Financing | •••••• | Jan 2026 | |
| Series B | •••••• | Sep 2025 | |
| Series C | •••••• | Mar 2025 | |
| Series A | •••••• | Jan 2025 | |
| Series A | •••••• | Nov 2024 | |
•••• ••••
|
Series A | •••••• | Aug 2024 |
|
•••• ••••
|
Series A | •••••• | Jul 2024 |
|
•••• ••••
|
Series D | •••••• | Apr 2024 |
|
•••• ••••
|
Series C | •••••• | Mar 2024 |
|
•••• ••••
|
Series B | •••••• | Jan 2024 |
Latest News
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Bioxconomy.com · Apr 08, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
